Backs, Johannes http://orcid.org/0000-0002-2322-2699
Article History
First Online: 13 June 2022
Competing interests
: J.B. is a scientific co-founder of Artemis Bio and collaborates with the LDC Dortmund and Novo Nordisk to develop CaMKII-HDAC4 inhibitory compounds.